Denosumab Boosts Bone Strength in Glucocorticoid Users

Compared with risedronate, denosumab promoted bone strength in patients initiating glucocorticoids and those on long-term therapy.
Medscape Medical News

source https://www.medscape.com/viewarticle/971978?src=rss